NASDAQ:IOVA
Examining the Potential Price Growth of Iovance Biotherapeutics Inc (IOVA)
Jaxson Clark
Iovance Biotherapeutics Inc’s recent filing unveils that its Chief Commercial Officer Kirby Daniel Gordon acquired Company’s shares for reported $55200.0 ...
The Potential Rise in the Price of Iovance Biotherapeutics Inc (IOVA) following insiders activity
Roman Campbell
Iovance Biotherapeutics Inc’s filing revealed that its Chief Commercial Officer Kirby Daniel Gordon acquired Company’s shares for reported $55200.0 on ...
Sharp increase in IOVA’s short interest leads to surge in days-to-cover ratio
Jaxson Clark
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
